
==== Front
Cancer Diagn Progn
Cancer Diagn Progn
Cancer Diagnosis & Prognosis
2732-7787
International Institute of Anticancer Research

10.21873/cdp.10366
Research Article
Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility
CHIN YU-TING 12
WU MING-HSIEN 34
SHIH HOU-YU 12
TSAI CHIA-WEN 12
PEI JEN-SHENG 5
KE TAO-WEI 2
WANG YUN-CHI 12
HUNG YI-CHIH 2
CHEN JAW-CHYUN 6
BAU DA-TIAN 127
CHANG WEN-SHIN 12
1 Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
2 Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
3 Division of Colon and Rectal Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.
4 National Defense Medical Center, Taipei, Taiwan, R.O.C.
5 Department of Pediatrics, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, R.O.C.
6 Department of Medicinal Botanicals and Foods on Health Applications, Da-Yeh University, Changhua, Taiwan, R.O.C.
7 Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C.
Da-Tian Bau and Wen-Shin Chang, Terry Fox Cancer Research Laboratory, China Medical University Hospital, 2 Yuh-Der Road, Taichung, 404 Taiwan, R.O.C. Tel: +886 422053366 Ext. 5805, email: halittlemelon@hotmail.com (W-S Chang); artbau2@gmail.com (D-T Bau)
1 9 2024
Sep-Oct 2024
4 5 579585
25 6 2024
9 7 2024
10 7 2024
©2024 The Author(s). Published by the International Institute of Anticancer Research.
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license
Background/Aim

The role of alcohol consumption and aldehyde dehydrogenase 2 (ALDH2) genotype in hepatocellular carcinoma (HCC) development remains uncertain.

Materials and Methods

We conducted genotyping of the ALDH2 rs671 single nucleotide polymorphism in 298 patients with HCC and 889 non-cancerous healthy controls. We assessed associations stratified by sex and alcohol consumption status.

Results

Distribution of ALDH2 rs671 variant genotypes differed significantly between HCC patients and controls (ptrend=0.0311). Logistic regression analyses indicated that compared to the wild-type GG genotype, the heterozygous variant AG genotype and homozygous variant AA genotype conferred 1.22- and 1.77-fold increases in HCC risk (p=0.1794 and 0.0150, respectively). Allelic frequency analysis showed that the A allele was associated with a 1.29-fold increased HCC risk (p=0.0123). Additionally, AA genotype carriers had significantly higher HCC risk than GG genotype carriers among males (p=0.0145) and non-alcohol drinkers (p<0.001).

Conclusion

HCC risk is influenced by ALDH2 genotype, with effects modified by sex and alcohol consumption. Particularly, individuals with the ALDH2 rs671 AA genotype should avoid alcohol consumption, especially males.

Alcohol drinking
aldehyde dehydrogenase 2 (ALDH2)
genotype
hepatocellular carcinoma
polymorphism
==== Body
pmcHepatocellular carcinoma (HCC) ranks sixth in global cancer prevalence and third in cancer-related mortality (1-3). Despite significant advancements in systematic therapies for HCC, including targeted therapy, immune checkpoint inhibitors, and intravenous chemotherapy, the 5-year recurrence rate remains high at 75% (4,5). HCC represents a formidable global public health challenge (6). Recently, genome-wide (7,8) and candidate gene studies (9-12), have revealed several potential diagnostic biomarkers for HCC. Nevertheless, identifying a clinically validated diagnostic marker remains challenging (13).

Aldehyde dehydrogenase 2 (ALDH2) is known for its role in ethanol metabolism, primarily expressed in liver mitochondria where it catalyzes the conversion of toxic acetaldehyde to acetic acid. Numerous studies have investigated associations between ALDH2 genotypes and various human diseases, including coronary artery stenosis (14), myocardial infarction (15), and ischemic stroke (16). Among single nucleotide polymorphisms (SNPs), ALDH2 rs671 is the most extensively studied, incorporating rs60823674, rs4986830, rs4134524, and rs2230021. Individuals carrying at least one variant allele of ALDH2 rs671 demonstrate significantly reduced enzymatic activity (17,18), leading to heightened sensitivity to alcohol, commonly referred to as "Asian Flush Syndrome" (19-21). Moreover, the AA genotype of ALDH2 rs671 has been linked to increased risks of upper digestive tract cancers and head and neck cancers (22,23). Furthermore, ALDH2 polymorphisms influence HCC development in non-alcoholic patients (24,25).

In the literature, several studies have indicated that the ALDH2 rs671 polymorphism does not correlate with HCC susceptibility in East Asian populations (26-29). Nevertheless, the influence of alcohol consumption patterns and ALDH2 rs671 genotypes on HCC development remains uncertain and warrants further investigation. Thus, our study aimed to explore the association between ALDH2 rs671 genotypes and the combined impact of alcohol drinking behaviors with ALDH2 rs671 genotypes on HCC risk in a representative Taiwanese population, comprising 298 HCC cases and 889 non-cancerous healthy controls.

Materials and Methods

Recruitment of HCC patients and non-cancerous control groups. Patients diagnosed with HCC by expert surgeons at China Medical University Hospital, Taiwan, were eligible for recruitment. HCC patients and non-cancerous healthy subjects who consented to complete a self-administered questionnaire and provided peripheral blood samples were enrolled in the study. Non-cancerous healthy controls, matched for age and sex, were selected from the Health Examination Cohort during the same period. The study design, including exclusion and inclusion criteria, was approved by the Institutional Review Board of China Medical University Hospital (DMR103-IRB-094). Table I summarizes selected information extracted from the questionnaire database of HCC cases and non-cancerous healthy subjects.

Table I Summary of selected characteristic data of the 298 patients with hepatocellular carcinoma and the matched 889 healthy controls.

SD: Standard deviation; abased on Student’s t-test and Chi-square test properly. *Statistically significant, p<0.05.

Genotyping methodology for ALDH2 rs671 polymorphism. Peripheral blood leukocytes from each participant were isolated using the QIAamp Blood Mini Kit (Blossom, Taipei, Taiwan, ROC), following procedures described in previous publications (30-32). PCR amplification of the ALDH2 rs671 polymorphic site was performed using specific primers: forward 5’-CAA ATT ACA GGG TCA ACT GC-3’ and reverse 5’-CCA CAC TCA CAG TTT TCT CTT-3’, followed by genotyping using PCR-restriction fragment length polymorphism analysis. Genotypic processing was independently conducted by trained researchers (Chang WS, Tsai CW, Wang YC, Shih HY, and Chin YT) in a double-blind manner. All repeated genotyping results were 100% concordant. The physical map illustrating the locations of ALDH2 rs671 is presented in Figure 1.

Figure 1 The physical map of polymorphic site for ALDH2 rs671 on chromosome 12.

Statistical methodology. Statistical analyses were conducted using SPSS version 16.0 software (SPSS, Inc., Chicago, IL, USA). The goodness-of-fit chi-square test assessed the Hardy-Weinberg equilibrium in the non-cancerous control group. The differential distributions of age between the HCC case and non-cancerous control groups were evaluated using Student’s t-test. Pearson’s chi-squared test with Yates’ correction examined the differential distribution of various ALDH2 genotypes and alleles. Associations between ALDH2 genotypes and HCC risk, as well as the combined impacts of ALDH2 genotypes with sex or alcoholism, were assessed through multivariable logistic regression analyses, calculating odds ratios (ORs) and corresponding 95% confidence intervals (CIs). A probability value ≤0.05 was considered statistically significant.

Results

The demographic data for the HCC populations. Table I presents the demographic characteristics including age, sex, smoking status, and alcohol consumption habits of the study participants, comprising 298 HCC patients and 889 non-cancerous healthy subjects. Utilizing a matching strategy ensured comparable age and sex distributions between cases and controls (both p>0.05) (Table I). The case group exhibited significantly higher proportions of ever smokers and ever alcohol drinkers compared to the control group (75.2% vs. 65.1% and 69.1% vs. 41.7%, respectively; p=0.0017 and 0.0011) (Table I). These results underscore the role of individual cigarette smoking and alcohol consumption as risk factors for HCC in Taiwan.

Associations of ALDH2 genotypes with HCC risk. Table II displays the distributions of ALDH2 rs671 genotypes among HCC cases and non-cancerous healthy controls. First, genotypic frequencies of the SNP in non-cancerous healthy controls were consistent with Hardy-Weinberg equilibrium (pHWE=0.8512). Second, ALDH2 rs671 genotype frequencies differed significantly between HCC cases and healthy controls, with higher proportions of the heterozygous variant AG and homozygous variant AA genotypes observed in HCC cases compared to controls (43.6% vs. 41.2% for AG and 12.4% vs. 8.1% for AA genotype, ptrend=0.0311). Logistic regression analyses revealed that the AA genotype was associated with an increased risk of HCC [odds ratio (OR)=1.77, 95% confidence interval (95%CI)=1.38-2.75, p=0.0150] relative to the wild-type GG genotype. In a dominant model analysis, individuals carrying variant genotypes (AG+AA) exhibited a 1.31-fold increased HCC risk (95%CI=1.01-1.71, p=0.0504, Table II).

Table II Genotypic frequency distributions of ALDH2 rs671 among the 298 hepatocellular carcinoma cases and 889 non-cancerous healthy controls.

OR: Odds ratio; CI: confidence interval; aData based on Chi-square test with Yates’ correction; ptrend: p-value based on trend analysis; pHWE: p-value based on Hardy-Weinberg Equilibrium; *Statistically significant.

Contributions of ALDH2 allelic frequencies to HCC risk. Table III presents the allelic frequencies of ALDH2 rs671 among HCC cases and non-cancerous healthy controls. Consistent with the results from Table II, individuals carrying the variant A allele of ALDH2 rs671 exhibited a higher risk of HCC compared to those with the wild-type G allele (OR=1.29, 95%CI=1.06-1.58, p=0.0123, Table III).

Table III Allelic frequencies for ALDH2 rs671 polymorphisms among the hepatocellular carcinoma cases and non-cancerous healthy controls.

OR: Odds ratio; CI: confidence internal; aData based on Chi-square test with Yates’ correction; *Statistically significant.

Stratified analysis of ALDH2 rs671 genotypes based on sex and alcohol drinking status. We attempted to investigate the combined impact of ALDH2 rs671 genotype with sex and alcohol consumption on HCC risk. Regarding sex, a significant interaction was observed between ALDH2 rs671 genotype and males (ptrend=0.0275), particularly among those carrying the AA genotype (p=0.0145, left part of Table IV). Conversely, no significant interaction was found between genotype and females, whether individuals were AG or AA carriers (p=0.9275 and 0.7003, right part of Table IV). This pattern persisted after adjusting for age, smoking, and alcohol consumption status (Table IV).

Table IV Distribution of ALDH2 rs671 genotypes among hepatocellular carcinoma cases and non-cancerous controls after stratification by sex.

N: Number; OR: odds ratio; CI: confidence interval; aBased on Chi-square with Yate’s correction test; bBased on Chi-square with Yate’s correction test after adjustment of age, cigarette smoking and alcohol drinking status. Statistically significant outcomes are shown in bold.

Regarding alcohol consumption status, a significant interaction was noted between ALDH2 rs671 genotype and non-drinkers (ptrend=7.9E-8), particularly among those with the AA genotype (p=0.0001, left part of Table V). Conversely, there was no significant interaction between ALDH2 rs671 genotype and drinkers, whether individuals carried AG or AA genotypes (p=0.2163 and 0.7191, right part of Table V). Adjusting for age, sex, and smoking status reaffirmed these findings (Table V).

Table V Distribution of ALDH2 rs671 genotypes among hepatocellular carcinoma cases and non-cancerous controls after stratification by alcoholism status.

N: Number; OR: odds ratio; CI: Confidence interval; aBased on Chi-square with Yate’s correction test; bBased on Chi-square with Yate’s correction test after adjustment of age, sex, and cigarette smoking status. Statistically significant outcomes are shown in bold.

Discussion

In the current study, we explored the role of alcohol consuming status and ALDH2 genotype in HCC development. The ALDH2 rs671 genotype is prevalent in East Asian populations, with frequencies ranging from 28-45%, contrasting its rarity in Western populations (33). Some studies suggest that carriers of the variant ALDH2 rs671 genotypes may self-select against alcohol consumption due to the acetaldehyde-induced flushing reaction (20,21). However, recent trends indicate increasing alcohol consumption among East Asian populations (34), potentially contributing to elevated HCC risk (35,36).

Our study highlights that the variant AA genotypes of ALDH2 rs671 are associated with increased HCC risk, particularly among males (Table II, Table III, and Table IV). Furthermore, the ALDH2 rs671 AA genotype significantly enhances HCC risk among non-alcohol drinkers (Table V, left part). These findings contrast with previous reports suggesting inconsistent associations between ALDH2 rs671 polymorphism and HCC risk in alcohol drinkers (37-40).

Of particular interest, our study suggests that the AA genotype of ALDH2 rs671 may lead to severe consequences for alcohol drinkers, potentially resulting in a biased OR estimate (Table V, right part). Conversely, the pronounced effects of the ALDH2 rs671 AA genotype among non-drinkers are evident (Table V, left part), potentially obscuring the inclusion of HCC cases with ALDH2 rs671 AA genotype who were alcohol drinkers and did not survive to be included in our study sample.

In the literature, the ALDH2 rs671 polymorphism has been reported to be associated with HCC risk among patients without alcoholism (24,25). This finding is consistent with our observation that among non-drinkers, carriers of the AA genotype at ALDH2 rs671 had a 7.6-fold increased OR for HCC risk (Table V, left part). However, a meta-analysis indicated that the ALDH2 rs671 polymorphism is not generally associated with HCC susceptibility in East Asian patients with HBV or hepatitis C virus (26). Furthermore, several studies have shown that the ALDH2 rs671 polymorphism is not associated with HCC in East Asian populations (26-29). These discrepancies may stem from differences in study designs that consider virus infections (26,28), or variations in the studied populations such as Japanese, distinct from the Han Chinese population examined in our study (27,29).

This study was conducted in a homogeneous cohort of HCC patients of Han Chinese descent, characterized by a significantly higher frequency of the ALDH2 rs671 "A" allele compared to other populations, as demonstrated in the 1000Genomes Project. Specifically, the ALDH2 rs671 "A" allele frequencies were nearly 0% in African, American, European, and South Asian populations, whereas they were 25.5% in East Asian populations with a sample size of 3,118 subjects (41). Consequently, it is crucial to emphasize that the predictive implications of this study are applicable primarily to East Asian populations. The combined effects of the ALDH2 rs671 genotype with alcohol consumption could not be broadly extrapolated to other populations.

Conclusion

This study provides evidence that variant genotypes at ALDH2 rs671 are associated with increased HCC risk, especially among males. Furthermore, these genotypes significantly elevate HCC risk among non-alcohol drinkers and may have severe consequences for alcohol drinkers. ALDH2 rs671 serves not only as a genetic susceptibility locus for HCC in Taiwanese populations but also as a critical predictor for potential life-threatening outcomes. Individuals carrying the ALDH2 rs671 A-allele, particularly those with the AA genotype, are advised to discontinue alcohol consumption promptly.

Conflicts of Interest

All the Authors declare no conflicts of interest regarding this study.

Authors’ Contributions

Conceptualization: Chin YT, Wu MH and Bau DT; Data curation: Wu MH, Pei JS, Ke TW and Hung YC; Investigation: Wu MH, Shih HY, Tsai CW, Wang YC and Chang WS; Formal analysis: Pei JS, Chen JC and Chang WS; Writing – original draft: Chang WS and Bau DT; Writing – review & editing: Chin YT, Wu MH, Shih HY, Tsai CW, Pei JS, Ke TW, Wang YC, Hung YC, Chen JC, Bau DT and Chang WS.

Acknowledgements

The Authors thank Yu-Cheng Luo and Yu-Hsin Yen for technical assistance in DNA extraction, aliquot and storage. This study was supported by grants from Taichung Armed Forces General Hospital (grant number: TCAFGH-D-111020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
==== Refs
1 Tian Z Xu C Yang P Lin Z Wu W Zhang W Ding J Ding R Zhang X Dou K Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma Front Immunol 2022 13 984728 10.3389/fimmu.2022.984728 36189208
2 McGlynn KA Petrick JL El-Serag HB Epidemiology of hepatocellular carcinoma Hepatology 2021 73 Suppl 1(Suppl 1) 4 13 10.1002/hep.31288
3 Sung H Ferlay J Siegel RL Laversanne M Soerjomataram I Jemal A Bray F Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 2021 71(3) 209 249 10.3322/caac.21660 33538338
4 Degasperi E Colombo M Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease Lancet Gastroenterol Hepatol 2016 1(2) 156 164 10.1016/S2468-1253(16)30018-8 28404072
5 Llovet JM Kelley RK Villanueva A Singal AG Pikarsky E Roayaie S Lencioni R Koike K Zucman-Rossi J Finn RS Hepatocellular carcinoma Nat Rev Dis Primers 2021 7(1) 6 10.1038/s41572-021-00245-6 33479224
6 Zhang Q Xu X Wu M Qin T Wu S Liu H MiRNA polymorphisms and hepatocellular carcinoma susceptibility: A systematic review and network meta-analysis Front Oncol 2021 10 562019 10.3389/fonc.2020.562019 33542895
7 Zhang J Zhang Q Hu W Liang Y Jiang D Chen H A transcriptome-wide association study identified susceptibility genes for hepatocellular carcinoma in East Asia Gastroenterol Rep (Oxf) 2024 12 goae057 10.1093/gastro/goae057 38846986
8 Hassan MM Li D Han Y Byun J Hatia RI Long E Choi J Kelley RK Cleary SP Lok AS Bracci P Permuth JB Bucur R Yuan JM Singal AG Jalal PK Ghobrial RM Santella RM Kono Y Shah DP Nguyen MH Liu G Parikh ND Kim R Wu HC El-Serag H Chang P Li Y Chun YS Lee SS Gu J Hawk E Sun R Huff C Rashid A Amin HM Beretta L Wolff RA Antwi SO Patt Y Hwang LY Klein AP Zhang K Schmidt MA White DL Goss JA Khaderi SA Marrero JA Cigarroa FG Shah PK Kaseb AO Roberts LR Amos CI Genome-wide association study identifies high-impact susceptibility loci for HCC in North America Hepatology 2024 80(1) 87 101 10.1097/HEP.0000000000000800 38381705
9 Yueh TC Tsao HY Chien WC Tsai CW Pei JS Wu MH Chen CP Chen CC Wang ZH Mong MC Yang YC Hung YC Bau DT Chang WS The Contribution of matrix metalloproteinase-7 promoter genotypes to hepatocellular carcinoma susceptibility Anticancer Res 2022 42(11) 5275 5282 10.21873/anticanres.16034 36288882
10 Lai YL Gong CL Fu CK Yueh TC Tsai CW Chang WS Hsiao CL Yen ST Li HT Jeng LB Wang SC Bau DT The Contribution of matrix metalloproteinase-1 genotypes to hepatocellular carcinoma susceptibility in Taiwan Cancer Genomics Proteomics 2017 14(2) 119 125 10.21873/cgp.20024 28387651
11 Chang WS Yang MD Tsai CW Cheng LH Jeng LB Lo WC Lin CH Huang CY Bau DT Association of cyclooxygenase 2 single-nucleotide polymorphisms and hepatocellular carcinoma in Taiwan Chin J Physiol 2012 55(1) 1 7 10.4077/CJP.2012.AMM056 22242948
12 Yousefi P Tabibzadeh A Jawaziri AK Mehrjoo M Akhavan M Allahqoli L Salehiniya H Autophagy-related genes polymorphism in hepatitis B virus-associated hepatocellular carcinoma: A systematic review Immun Inflamm Dis 2024 12(2) e1182 10.1002/iid3.1182 38353395
13 Pandyarajan V Govalan R Yang JD Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma Int J Mol Sci 2021 22(2) 479 10.3390/ijms22020479 33418899
14 Rao H Wang X Luo Y Liang L Ye W Guo X Aldehyde dehydrogenase 2 rs671 a/A genotype is associated with an increased risk of early onset coronary artery stenosis Int J Gen Med 2024 17 2407 2415 10.2147/IJGM.S461004 38813240
15 Lamb RJ Griffiths K Lip GY Sorokin V Frenneaux MP Feelisch M Madhani M ALDH2 polymorphism and myocardial infarction: From alcohol metabolism to redox regulation Pharmacol Ther 2024 259 108666 10.1016/j.pharmthera.2024.108666 38763322
16 Liu Y Wang W Cui X Lyu J Xie Y Exploring genetic associations of 3 types of risk factors with ischemic stroke: An integrated bioinformatics study Stroke 2024 55(6) 1619 1628 10.1161/STROKEAHA.123.044424 38591222
17 Enomoto N Takase S Yasuhara M Takada A Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes Alcohol Clin Exp Res 1991 15(1) 141 144 10.1111/j.1530-0277.1991.tb00532.x 2024727
18 Harada S Polymorphism of aldehyde dehydrogenase and its application to alcoholism Electrophoresis 1989 10(8-9) 652 655 10.1002/elps.1150100820 2806215
19 Matsuo K Hamajima N Hirai T Kato T Koike K Inoue M Takezaki T Tajima K Aldehyde dehydrogenase 2 (ALDH2) genotype affects rectal cancer susceptibility due to alcohol consumption J Epidemiol 2002 12(2) 70 76 10.2188/jea.12.70 12033531
20 Huang PH Hu CC Chien CH Chen LW Chien RN Lin YS Chao M Lin CL Yeh CT The defective allele of aldehyde dehydrogenase 2 gene is associated with favorable postoperative prognosis in hepatocellular carcinoma J Cancer 2019 10(23) 5735 5743 10.7150/jca.33221 31737110
21 Liao WL Chan FC Chang KP Chang YW Chen CH Su WH Chang HH Associations between ALDH genetic variants, alcohol consumption, and the risk of nasopharyngeal carcinoma in an east asian population Genes (Basel) 2021 12(10) 1547 10.3390/genes12101547 34680942
22 Boonyaphiphat P Thongsuksai P Sriplung H Puttawibul P Lifestyle habits and genetic susceptibility and the risk of esophageal cancer in the Thai population Cancer Lett 2002 186(2) 193 199 10.1016/s0304-3835(02)00354-3 12213289
23 Itoga S Nomura F Makino Y Tomonaga T Shimada H Ochiai T Iizasa T Baba M Fujisawa T Harada S Tandem repeat polymorphism of the CYP2E1 gene: an association study with esophageal cancer and lung cancer Alcohol Clin Exp Res 2002 26(8 Suppl) 15S 19S 10.1097/01.ALC.0000026828.13868.B5 12198369
24 Ye X Wang X Shang L Zhu G Su H Han C Qin W Li G Peng T Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population Cancer Manag Res 2018 10 1037 1050 10.2147/CMAR.S162105 29765251
25 Tomoda T Nouso K Sakai A Ouchida M Kobayashi S Miyahara K Onishi H Nakamura S Yamamoto K Shimizu K Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: A case control study J Gastroenterol Hepatol 2012 27(4) 797 804 10.1111/j.1440-1746.2011.06948.x 22004425
26 Chen J Pan W Chen Y Wen L Tu J Liu K Relationship of ALDH2 rs671 and CYP2E1 rs2031920 with hepatocellular carcinoma susceptibility in East Asians: A meta-analysis World J Surg Oncol 2020 18(1) 21 10.1186/s12957-020-1796-0 31987047
27 Koide T Ohno T Huang XE Iijima Y Sugihara K Mizokami M Xiang J Tokudome S HBV/HCV infection, alcohol, tobacco and genetic polymorphisms for hepatocellular carcinoma in Nagoya, Japan Asian Pac J Cancer Prev 2000 1(3) 237 243 12718671
28 Yu SZ Huang XE Koide T Cheng G Chen GC Harada K Ueno Y Sueoka E Oda H Tashiro F Mizokami M Ohno T Xiang J Tokudome S Hepatitis B and C viruses infection, lifestyle and genetic polymorphisms as risk factors for hepatocellular carcinoma in Haimen, China Jpn J Cancer Res 2002 93(12) 1287 1292 10.1111/j.1349-7006.2002.tb01236.x 12495467
29 Takeshita T Yang X Inoue Y Sato S Morimoto K Relationship between alcohol drinking, ADH2 and ALDH2 genotypes, and risk for hepatocellular carcinoma in Japanese Cancer Letters 2000 149(1-2) 69 76 10.1016/s0304-3835(99)00343-2 10737710
30 Chen LH Tsai YF Wu WT Chiu KL Tsai CW Chang WS Li CH Yang JS Mong MC Hsia TC Bau DT Association of matrix metalloproteinase-9 genotypes with lung cancer risk in Taiwan Anticancer Res 2024 44(5) 1845 1852 10.21873/anticanres.16986 38677770
31 Liao CH Chien WC Chang SY Lin YH Wang YC Huang WC Mong MC Yang YC Wu WT Chen JC Chang CH Tsai CW Bau DT Chang WS Associations of matrix metalloproteinase-8 genotypes to renal cell carcinoma in Taiwan Anticancer Res 2024 44(5) 1931 1938 10.21873/anticanres.16995 38677743
32 Chiu KL Wang SC Li CH Shen TC Chen LH Shen YC Chang WS Tsai CW Hsia TC Bau DT The contribution of double-strand break repair radiation sensitive protein 51 genotypes to lung cancer in Taiwan Anticancer Res 2024 44(4) 1409 1416 10.21873/anticanres.16937 38537967
33 Wu CF Wu DC Hsu HK Kao EL Lee JM Lin CC Wu MT Relationship between genetic polymorphisms of alcohol and aldehyde dehydrogenases and esophageal squamous cell carcinoma risk in males World J Gastroenterol 2005 11(33) 5103 5108 10.3748/wjg.v11.i33.5103 16127737
34 Chen YJ Chen C Wu DC Lee CH Wu CI Lee JM Goan YG Huang SP Lin CC Li TC Chou YP Wu MT Interactive effects of lifetime alcohol consumption and alcohol and aldehyde dehydrogenase polymorphisms on esophageal cancer risks Int J Cancer 2006 119(12) 2827 2831 10.1002/ijc.22199 17036331
35 Hsieh YH Chang WS Tsai CW Tsai JP Hsu CM Jeng LB Bau DT DNA double-strand break repair gene XRCC7 genotypes were associated with hepatocellular carcinoma risk in Taiwanese males and alcohol drinkers Tumour Biol 2015 36(6) 4101 4106 10.1007/s13277-014-2934-5 25944161
36 Yang MD Hsu CM Chang WS Yueh TC Lai YL Chuang CL Wang SC Jeng LB Ji HX Hsiao CL Wu CN Tsai CW Chung JG Bau DT Tumor necrosis factor-alpha genotypes are associated with hepatocellular carcinoma risk in Taiwanese males, smokers and alcohol drinkers Anticancer Res 2015 35(10) 5417 5423 26408704
37 Seo W Gao Y He Y Sun J Xu H Feng D Park SH Cho YE Guillot A Ren T Wu R Wang J Kim SJ Hwang S Liangpunsakul S Yang Y Niu J Gao B ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles J Hepatol 2019 71(5) 1000 1011 10.1016/j.jhep.2019.06.018 31279903
38 Abe H Aida Y Seki N Sugita T Tomita Y Nagano T Itagaki M Sutoh S Nagatsuma K Itoh K Matsuura T Aizawa Y Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis J Gastroenterol Hepatol 2015 30(9) 1376 1383 10.1111/jgh.12948 25778454
39 Liu J Yang HI Lee MH Jen CL Hu HH Lu SN Wang LY You SL Huang YT Chen CJ Alcohol drinking mediates the association between polymorphisms of ADH1B and ALDH2 and hepatitis B-related hepatocellular carcinoma Cancer Epidemiol Biomarkers Prev 2016 25(4) 693 699 10.1158/1055-9965.EPI-15-0961 26827895
40 Sakamoto T Hara M Higaki Y Ichiba M Horita M Mizuta T Eguchi Y Yasutake T Ozaki I Yamamoto K Onohara S Kawazoe S Shigematsu H Koizumi S Tanaka K Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population Int J Cancer 2006 118(6) 1501 1507 10.1002/ijc.21505 16187278
41 dbSNP rs671 Available at: https://www.ncbi.nlm.nih.gov/snp/rs671 [Last accessed on June 24, 2024]
